AU Stock MarketDetailed Quotes

PAR Paradigm Biopharmaceuticals Ltd

Watchlist

0.325
+0.055+20.37%

20min DelayNot Open Nov 22 16:00 AET

113.56MMarket Cap-1625P/E (Static)

Paradigm Biopharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Paradigm Biopharmaceuticals Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/FY	65.800K / 0.000	--
--	2023/FY	46.760K / 5.000K	--
--	2022/FY	79.220K / --	--
--	2021/FY	8.942M / 3.400M	--
--	2020/FY	4.695M / 2.625M	--

DatePeriodRevenue/EstimateEarnings Call

--2024/FY65.800K / 0.000--

--2023/FY46.760K / 5.000K--

--2022/FY79.220K / ----

--2021/FY8.942M / 3.400M--

--2020/FY4.695M / 2.625M--

Unlock Free Earnings Estimates

Open Account

Paradigm Biopharmaceuticals Ltd Earnings Reports

Paradigm Biopharmaceuticals Ltd: Appendix 4E and 2024 Annual Report

Aug 29 20:53 ET

Paradigm Biopharmaceuticals Ltd: Half Yearly Report and Accounts

Feb 27 20:15 ET

Paradigm Biopharmaceuticals Ltd: 2023 Annual Report and Appendix 4E

Aug 25, 2023 01:53 ET

Paradigm Biopharmaceuticals Ltd: Half Yearly Report and Accounts

Feb 26, 2023 17:57 ET

Analyst Rating

Updated: Nov 3, 2024

Strong Buy

Strong Buy
100.00%
Buy
0.00%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall